Biotech

All Articles

ArsenalBio increases $325M, turns far from previous lead property

.Toolbox Biosciences is moving on up. The cell therapy business has added on $325 thousand in ammuni...

Lilly- backed weight loss biotech data IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has submitte...

Aelis' cannabis make use of medication fails phase 2b, driving Indivior to re-think $100M option

.Aelis Farma's chances of getting an easy, good decision on a $100 million option remittance have fa...

ProKidney stops stage 3 trial not needed for cell treatment confirmation

.ProKidney has actually quit among a set of stage 3 tests for its own tissue treatment for kidney co...

Vaxcyte surges on 'magnificent' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what professionals referred to as "stunning" period 1/2 records for its 31-valent ...

Recursion's brain illness test shows little evidence of effectiveness

.Recursion has actually stumbled with a very early exam of its tech-enabled technique to medication ...

Acepodia, Pfizer click all together for chemistry-based cell treatment

.Contact it an instance of really good chemistry: Acepodia, a biotech based on Nobel Prize-winning s...

Praxis epilepsy medication reduces confiscations in period 2 litigation

.Praxis Precision Medicines has actually racked up yet another midphase succeed in epilepsy this yea...

Three officers surrender as Dyne blog posts blended records for DMD prospect

.After escaping a medical hold a number of years back, Dyne Therapeutics has exposed brand-new stage...

Arrowhead fires off phase 3 records in unusual metabolic health condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually revealed its hand in advance of a possible face-off with Ion...